Correlation Analysis Between Cortical Structural Features and Acoustic Features in Patients With Parkinson's Disease.

Purpose: Parkinson disease (PD) is a progressive neurodegenerative disease. The aim of this study is to investigate the association between acoustic and cortical brain features in Parkinson's disease patients.

Methods: We recruited 19 (eight females, 11 males) Parkinson's disease patients and 19 (eight females, 11 males) healthy subjects to participate in the experiment.

Lie Detection Based on Acoustic Analysis.

Purpose: Acoustic lie detection, prized for its covert nature and capability for remote processing, has spurred growing interest in acoustic features that can reliably aid in lie detection. In this study, the aim was to construct an acoustic polygraph based on a variety of phonetic and acoustic features rather than on electrodermal, cardiovascular, and respiratory values.

Methods: Sixty-two participants from the University of Science and Technology of China, aged 18-30 years old, were involved in the mock crime experiment and were randomly assigned to the innocent and guilty groups.

A Study on Voice Measures in Patients with Parkinson's Disease.

Purpose: This research aims to identify acoustic features which can distinguish patients with Parkinson's disease (PD patients) and healthy speakers.

Methods: Thirty PD patients and 30 healthy speakers were recruited in the experiment, and their speech was collected, including three vowels (/i/, /a/, and /u/) and nine consonants (/p/, /pʰ/, /t/, /tʰ/, /k/, /kʰ/, /l/, /m/, and /n/). Acoustic features like fundamental frequency (F0), Jitter, Shimmer, harmonics-to-noise ratio (HNR), first formant (F1), second formant (F2), third formant (F3), first bandwidth (B1), second bandwidth (B2), third bandwidth (B3), voice onset, voice onset time were analyzed in our experiment.

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients.

Objective: The low-density lipoprotein cholesterol goals in the 2019 European Society of Cardiology/European Atherosclerosis Society dyslipidaemia guidelines necessitate greater use of combination therapies. We describe a real-world cohort of patients in Austria and simulate the addition of oral bempedoic acid and ezetimibe to estimate the proportion of patients reaching goals.

Methods: Patients at high or very high cardiovascular risk on lipid-lowering treatments (excluding proprotein convertase subtilisin/kexin type 9 inhibitors) from the Austrian cohort of the observational SANTORINI study were included using specific criteria.

A Study on Voice Measures in Patients With Alzheimer's Disease.

Objective: As Alzheimer's disease (AD) might provoke certain nerve disorders, patients with AD can acquire sensorimotor adaptation problems, and thus the acoustic characteristics of the speech they produce may differ from those of healthy subjects. This study aimed to (1) extract acoustic characteristics (relating to articulatory gestures) potentially useful for detecting AD and (2) examine whether these characteristics could help identify AD patients.

Methods: A total of 50 individuals participated in the study, including the AD group (17 cases), the Neurologically Healthy (NH) group (13 cases), the Mild Cognitive Impairment (MCI) group (11 cases), and the Vascular Cognitive Impairment (VCI) group (9 cases).